Elevated IP-10 and IL-6 from bronchoalveolar lavage cells are biomarkers of non-cavitary tuberculosis
- PMID: 23743311
- PMCID: PMC4050635
- DOI: 10.5588/ijtld.12.0610
Elevated IP-10 and IL-6 from bronchoalveolar lavage cells are biomarkers of non-cavitary tuberculosis
Abstract
Background: Active TB disease can destroy lung parenchyma leading to cavities. Immune responses that predispose or protect individuals from lung damage during TB are poorly defined.
Objective: To sample lung immune cells and assay bronchoalveolar lavage (BAL) cell cytokine production.
Design: Enrolled subjects (n = 73) had bilateral infiltrates and underwent BAL.
Results: All had sputum culture demonstrating Mycobacterium tuberculosis and 22/73 (30%) had cavities on their chest radiograph. Those with cavities at presentation had a higher percentage of polymorphonuclear neutrophils (PMN) in BAL as well as lower inducible protein (IP) 10 (P < 0.01) and interleukin (IL) 6 (P = 0.013) in BAL cell supernatants compared to those without cavities. There was no correlation between cavities and other BAL or serum cytokines. IP-10 was negatively associated with BAL PMN. IP-10 and IL-6 expression above median reduces the odds of cavities by 79% and 78% in logistic regression models. IP-10 and IL-6 clustered with interferon-gamma and tumour necrosis factor-alpha in a principal component analysis, while IL-4 clustered with PMN.
Conclusion: Increasing IP-10 and IL-6 production by BAL cells is associated with non-cavitary TB in patients who present with radiographically advanced TB. IP-10 and IL-6 may reflect an effective T-helper 1 immune control pathway for TB, attenuating tuberculous lung destruction.
Figures



Similar articles
-
Increased production of IL-4 and IL-12p40 from bronchoalveolar lavage cells are biomarkers of Mycobacterium tuberculosis in the sputum.PLoS One. 2013;8(3):e59461. doi: 10.1371/journal.pone.0059461. Epub 2013 Mar 20. PLoS One. 2013. PMID: 23527200 Free PMC article.
-
Bronchoalveolar neutrophils, interferon gamma-inducible protein 10 and interleukin-7 in AIDS-associated tuberculosis.Clin Exp Immunol. 2007 May;148(2):254-9. doi: 10.1111/j.1365-2249.2007.03330.x. Epub 2007 Feb 7. Clin Exp Immunol. 2007. PMID: 17286802 Free PMC article.
-
Local immune responses correlate with presentation and outcome in tuberculosis.Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):729-35. doi: 10.1164/ajrccm.157.3.9705044. Am J Respir Crit Care Med. 1998. PMID: 9517583
-
CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients.Clin Immunol. 1999 Sep;92(3):224-34. doi: 10.1006/clim.1999.4752. Clin Immunol. 1999. PMID: 10479527
-
The Immune Mechanisms of Lung Parenchymal Damage in Tuberculosis and the Role of Host-Directed Therapy.Front Microbiol. 2018 Oct 30;9:2603. doi: 10.3389/fmicb.2018.02603. eCollection 2018. Front Microbiol. 2018. PMID: 30425706 Free PMC article. Review.
Cited by
-
Azithromycin as Host-Directed Therapy for Pulmonary Tuberculosis: A Randomized Pilot Trial.J Infect Dis. 2025 Jun 2;231(5):e891-e900. doi: 10.1093/infdis/jiaf069. J Infect Dis. 2025. PMID: 39932906 Free PMC article. Clinical Trial.
-
Chemokines in tuberculosis: the good, the bad and the ugly.Semin Immunol. 2014 Dec;26(6):552-8. doi: 10.1016/j.smim.2014.09.004. Epub 2014 Oct 22. Semin Immunol. 2014. PMID: 25444549 Free PMC article. Review.
-
Human Pulmonary Tuberculosis: Understanding the Immune Response in the Bronchoalveolar System.Biomolecules. 2022 Aug 20;12(8):1148. doi: 10.3390/biom12081148. Biomolecules. 2022. PMID: 36009042 Free PMC article. Review.
-
Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals.PLoS One. 2017 Nov 10;12(11):e0187882. doi: 10.1371/journal.pone.0187882. eCollection 2017. PLoS One. 2017. PMID: 29125874 Free PMC article.
-
NF-κB repressing factor inhibits chemokine synthesis by peripheral blood mononuclear cells and alveolar macrophages in active pulmonary tuberculosis.PLoS One. 2013 Nov 4;8(11):e77789. doi: 10.1371/journal.pone.0077789. eCollection 2013. PLoS One. 2013. PMID: 24223729 Free PMC article.
References
-
- Global Tuberculosis Control World Health Organization [Internet] 20112011 Available from: http://www.who.int/tb/publications/global_report/2011.
-
- Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, et al. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. The New England journal of medicine. 1989;320(9):545–50. Epub 1989/03/02. - PubMed
-
- Dheda K, Migliori GB. The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue? Lancet. 2012;379(9817):773–5. Epub 2011/10/29. - PubMed
-
- Dheda K, Chang JS, Breen RA, Haddock JA, Lipman MC, Kim LU, et al. Expression of a novel cytokine, IL-4delta2, in HIV and HIV-tuberculosis co-infection. AIDS. 2005;19(15):1601–6. Epub 2005/09/27. - PubMed
-
- Dheda K, Booth H, Huggett JF, Johnson MA, Zumla A, Rook GA. Lung remodeling in pulmonary tuberculosis. The Journal of infectious diseases. 2005;192(7):1201–9. Epub 2005/09/02. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources